SalioGen Therapeutics

BiotechnologySeries BBurlington, USsaliogen.com

Latest round

Series B

Last raised

Nov 2021

Total raised

$95M

Investors

9

About SalioGen Therapeutics

Based in Massachusetts, US, and founded in 2020, SalioGen Therapeutics, Inc. operates as a biotechnology company developing Gene Coding. Ray Tabibiazar serves as the CEO, and Chairman of the company as of 2021. In January 2022, SalioGen Therapeutics, Inc. The company is the developer of Gene Coding, a genetic medicine platform that uses its Exact DNA Integration Technology (EDIT) to give patients with inherited disorders, effective and broadly applicable non-viral gene therapy. The company's mammalian-derived genome editing technology will be employed in possibly curative nonviral gene therapy, allowing the healthcare industry to cure people in need.

Who invested in SalioGen Therapeutics

9 investors across 2 rounds

See all investors in SalioGen Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Nov 24, 2021

    Amount

    $75M

    Investors

    Locked

  2. Series A

    Feb 4, 2021

    Amount

    $20M

    Investors

    Locked

Questions about SalioGen Therapeutics

Who invested in SalioGen Therapeutics?

SalioGen Therapeutics has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has SalioGen Therapeutics raised?

SalioGen Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did SalioGen Therapeutics last raise money?

SalioGen Therapeutics's most recent round on record is a Series B, in Nov 2021.

What does SalioGen Therapeutics do?

Based in Massachusetts, US, and founded in 2020, SalioGen Therapeutics, Inc.

Where is SalioGen Therapeutics headquartered?

SalioGen Therapeutics is headquartered in Burlington, US.

Which VCs invest in companies like SalioGen Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at SalioGen Therapeutics's stage. Their profiles are linked below.

Raising like SalioGen Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.